Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 8 PART1, 2008, Pages 1250-1258

  Ma, Hui ^a   Wei, Lai ^a   Guo, Fang ^a   Zhu, Sainan ^b   Sun, Yan ^a   Wang, Hao ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Chinese patients; HBeAg negative; Liver cirrhosis; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEMOGLOBIN; HEPATITIS B(E) ANTIBODY;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA VIRUS; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; VIRUS LOAD;

EID: 48549096037     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05499.x     Document Type: Article

References (24)

1. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations. AASLD Practice guideline. Hepatology 2004 39 : 857 61.
2. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988 8 : 493 6.
3. De Jongh FE, Janssen HL, De Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992 103 : 1630 5.
4. Fattovich G, Giustina G, Schalm SW et al. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology 1995 21 : 77 82.
5. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Hepatitis B. Summary of a Clinical Research Workshop. Hepatology 2007 45 : 1056 75.
6. Hadziyannis SJ, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res 2001 52 : 91 8.
7. Brunetto MR, Oliveri F, Rocca G et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989 10 : 198 202.
8. Yuen MF, Yuan HJ, Hui CK et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 2003 52 : 416 19.
9. Yu MW, Hsu FC, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am. J. Epidemiol. 1997 145 : 1039 47.
10. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 33 : 464 70.
11. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973 60 : 646 9.
12. Fattovich G, Brollo L, Alberti A, Pontisso P, Giustina G, Realdi G. Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology 1988 8 : 1651 4.
13. Lai CL, Yuen MF. The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann. Intern. Med. 2007 147 : 58 61.
14. McMahon BJ. The natural history of chronic hepatitis B virus infection. Semin. Liver Dis. 2004 24 (Suppl. 1 17 21.
15. Li JQ, Zhuang H, Du H, Wang XH, Duan XZ. Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis. Zhonghua Ganzangbing Zazhi 2005 13 : 491 3.
16. Fattovich G, Brollo L, Giustina G et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991 32 : 294 8.
17. Enomoto M, Tamori A, Nishiguchi S. Hepatitis B virus genotypes and response to antiviral therapy. Clin. Lab. 2006 52 : 43 7.
18. Botta F, Giannini E, Romagnoli P et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003 52 : 134 9.
19. Villeneuve JP, Condreay LD, Willems B et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000 31 : 207 10.
20. Realdi G, Alberti A, Rugge M et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980 79 : 195 9.
21. Fattovich G, Rugge M, Brollo L et al. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986 6 : 167 72.
22. Fattovich G. Natural history and prognosis of Hepatitis B. Semin. Liver Dis. 2003 23 : 47 59.
23. Planas R, Ballesté B, Álvarez MA et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J. Hepatol. 2004 40 : 823 30.
24. Chen CJ, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006 295 : 65 73.